甲状腺滤泡癌术前诊断方法的研究进展

摘要

甲状腺滤泡癌（FTC）是除甲状腺乳头状癌外最常见的分化型甲状腺癌，侵袭性强，患者预后相对较差。手术是FTC的主要治疗方式。但术前难以与甲状腺滤泡性腺瘤（FA）区分，往往导致手术范围不足或过度治疗。近年来，随着多组学与人工智能技术的发展，多模式超声、分子生物学标志物及基于超声影像的深度学习模型等也取得显著进展。本文探讨新技术新方法在FTC术前诊断中的应用，以期为临床决策提供参考。

关键词

甲状腺滤泡癌 / 术前诊断 / 进展

参考文献

[1] Dralle H , Machens A , Basa J , et al. Follicular cell—derived thyroid cancer[J]. Nat Rev Dis Primers, 2015, 1: 15077. DOI: 10.1038/nrdp.2015.77.

[2] Miranda—Filho A , Lortet—Tieulent J , Bray F , et al. Thyroid cancer incidence trends by histology in 25 countries: a population—based study[J]. Lancet Diabetes Endo, 2021, 9(4): 225-234. DOI: 10.1016/S2213—8587(21)00027—9.

[3] Kammori M , Fukumori T , Sugishita Y . Therapeutic strategy for low—risk thyroid cancer in Kanaji Thyroid Hospital[J]. Endocr J, 2014, 61(1): 1-12. DOI: 10.1507/endocrj.ej13—0284.

[4] Kitahara CM , Schneider AB . Epidemiology of thyroid cancer[J]. Cancer Epidem Biomar, 2022, 31(7): 1284-1297. DOI: 10.1158/1055—9965.EPI—21—1440.

[5] Omar B , Yassir H , Youssef O , et al. A rare case of follicular thyroid carcinoma metastasis to the sacral region: A case report with literature review[J]. Int J Surg Case Rep, 2022, 94: 107001. DOI: 10.1016/j.ijscr.2022.107001.

[6] 中华医学会内分泌学分会， 中华医学会外科学分会甲状腺及代谢外科组， 中国抗癌协会头颈肿瘤专业委员会， 等 . 甲状腺结节和分化型甲状腺癌诊治指南（第二版）[J]. 中华内分泌代谢杂志， 2023， 39（3）： 181-226. DOI: 10.3760/cma.j.cn311282—20221023—00589.

[7] Kushchayeva Y , Duh QY , Kebebew E , et al. Comparison of clinical characteristics at diagnosis and during follow—up in 118 patients with Hurthle cell or follicular thyroid cancer[J]. Am J Surg, 2008, 195(4): 457-462. DOI: 10.1016/j.amjsurg.2007.06.001.

[8] Sugino K , Ito K , Nagahama M , et al. Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma[J]. Thyroid, 2011, 21(7): 751-757. DOI: 10.1089/thy.2010.0353.

[9] Kim HJ , Chung JH . Reply to letter to the editor regarding association of vascular invasion with increased mortality in patients with minimally invasive follicular thyroid carcinoma but not widely invasive follicular thyroid carcinoma[J]. Head Neck, 2016, 38(1): 159. DOI: 10.1002/hed.24208.

[10] Grani G , Lamartina L , Durante C , et al. Follicular thyroid cancer and Hürthle cell carcinoma: challenges in diagnosis, treatment, and clinical management[J]. Lancet Diabetes Endo, 2018, 6(6): 500-514. DOI: 10.1016/s2213—8587(17)30325—x.

[11] Park JW , Kim DW , Kim D , et al. Korean thyroid imaging reporting and data system features of follicular thyroid adenoma and carcinoma: a single—center study[J]. Ultrasonography, 2017, 36(4): 349-354. DOI: 10.14366/usg.17020.

[12] Liu BJ , Zhang YF , Zhao CK , et al. Conventional ultrasound characteristics, TI—RADS category and shear wave speed measurement between follicular adenoma and follicular thyroid carcinoma[J]. Clin Hemorheol Micro, 2020, 75(3): 291-301. DOI: 10.3233/CH—190750.

[13] 李婷， 陈露， 李媛， 等 . 甲状腺滤泡性腺瘤与滤泡癌的超声检查特征分析[J]. 医学影像学杂志， 2024， 34（8）： 30-32.

[14] Kobayashi K , Hirokawa M , Yabuta T , et al. Tumor protrusion with intensive blood signals on ultrasonography is a strongly suggestive finding of follicular thyroid carcinoma[J]. Med Ultrason, 2016, 18(1): 25-29. DOI: 10.11152/mu.2013.2066.181.kok.

[15] Zhang F , Mei F , Chen W , et al. Role of ultrasound and ultrasound—based prediction model in differentiating follicular thyroid carcinoma from follicular thyroid adenoma[J]. J Ultras Med, 2024, 43(8): 1389-1399. DOI: 10.1002/jum.16461.

[16] Xu R , Wen W , Zhang Y , et al. Diagnostic significance of ultrasound characteristics in discriminating follicular thyroid carcinoma from adenoma[J]. BMC Med Imaging, 2024, 24(1): 1-10. DOI: 10.1186/s12880—024—01477—0.

[17] Li J , Li C , Zhou X , et al. US risk stratification system for follicular thyroid neoplasms[J]. Radiology, 2023, 309(2): 1-12. DOI: 10.1148/radiol.230949.

[18] 王晓娜， 汪威， 刘倩， 等 . 滤泡状甲状腺癌术前预测模型的建立与验证[J]. 中国现代普通外科进展， 2022， 25（9）： 702-706. DOI: 10.3969/j.issn.1009—9905.2022.09.006.

[19] 苏一轩， 应涛 . 甲状腺滤泡性肿瘤超声诊断新进展[J]. 外科理论与实践， 2025， 30（1）： 21-26. DOI: 10.16139/j. 1007—9610. 2025.01.05.

[20] 江琼， 林友国 . 甲状腺滤泡状腺癌与良性结节的超声鉴别诊断[J]. 实用医学影像杂志， 2023， 24（3）： 221-225. DOI:10.16106/j. cnki.cn14—1281/r. 2023.03.015.

[21] Na HY , Moon JH , Choi JY , et al. Preoperative diagnostic categories of fine needle aspiration cytology for histologically proven thyroid follicular adenoma and carcinoma, and Hurthle cell adenoma and carcinoma: Analysis of cause of under— or misdiagnoses[J]. PLoS One, 2020, 15(11): e0241597. DOI: 10.1371/journal.pone.0241597.

[22] Baloch ZW , Asa SL , Barletta JA , et al. Overview of the 2022 WHO classification of thyroid neoplasms[J]. Endocr Pathol, 2022, 33(1): 27-63. DOI: 10.1007/s12022—022—09707—3.

[23] Gigliotti BJ , Israel A—K , Winslow TB , et al. Advances in follicular thyroid cancer diagnosis and management[J]. Endocrin Metab Clin, 2025, 54(3): 341-360. DOI: 10.1016/j.ecl.2025.03.008.

[24] Fukahori M , Yoshida A , Hayashi H , et al. The associations between RAS mutations and clinical characteristics in follicular thyroid tumors: new insights from a single center and a large patient cohort[J]. Thyroid, 2012, 22(7): 683-689. DOI: 10.1089/thy.2011.0261.

[25] Song YS , Lim JA , Min HS , et al. Changes in the clinicopathological characteristics and genetic alterations of follicular thyroid cancer[J]. Eur J Endocrinol, 2017, 177(6): 465-473. DOI: 10.1530/EJE—17—0456.

[26] Haugen BR , Alexander EK , Bible KC , et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2016, 26(1): 1-133. DOI: 10.1089/thy.2015.0020.

[27] Sun Y , Wang H , Li L , et al. A protein—based classifier for differentiating follicular thyroid adenoma and carcinoma[J]. EMBO Mol Med, 2025, 17(7): 1519-1538. DOI: 10.1038/s44321—025—00242—2.

[28] N.Shivapurkar, A.F.Gazdar. DNA Methylation based biomarkers in nonInvasive cancer screening[J]. Curr Mol Med, 2010, 10: 123-132. DOI: 10.2174/156652410790963303.

[29] Yao Y , Xu P , Ying T , et al. Integrative analysis of DNA methylation and gene expression identified follicular thyroid cancer—specific diagnostic biomarkers[J]. Front Endocrinol, 2021, 12: 736068. DOI: 10.3389/fendo.2021.736068.

[30] Lin SF , Lin JD , Chou TC , et al. Utility of a histone deacetylase inhibitor(PXD101) for thyroid cancer treatment[J]. Plos One, 2013, 8(10): e77684. DOI: 10.1371/journal.pone.0077684.

[31] Dai Y , Miao Y , Zhu Q , et al. Expression of long non—coding RNA H19 predicts distant metastasis in minimally invasive follicular thyroid carcinoma[J]. Bioengineered, 2019, 10(1): 383-389. DOI: 10.1080/21655979.2019.1658489.

[32] Cai X , Sun R , Yang L , et al. Proteomic analysis reveals modulation of key proteins in follicular thyroid cancer progression[J]. Chin Med J (Engl), 2025. DOI: 10.1097/CM9.0000000000003645.

[33] Zheng Y , Zhang Y , Lu K , et al. Diagnostic value of an interpretable machine learning model based on clinical ultrasound features for follicular thyroid carcinoma[J]. Quant Imag Med Surg, 2024, 14(9): 6311-6324. DOI: 10.21037/qims—24—601.

[34] Agyekum EA , Yuzhi Z , Fang Y , et al. Ultrasound—based classification of follicular thyroid Cancer using deep convolutional neural networks with transfer learning[J]. Sci Rep—UK, 2025, 15(1): 1-12. DOI: 10.1038/s41598—025—05551—7.

[35] Wang Y , Lu W , Xu L , et al. Deep learning—based ultrasound diagnostic model for follicular thyroid carcinoma[J]. Eur Radiol, 2025: 1-10. DOI: 10.1007/s00330—025—11840—6.